Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Person › Details

Barbara Krebs-Pohl (MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR))

Krebs-Pohl, Barbara (MorphoSys –200603– Head BusDev)

 

Organisation Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
Products Product Ylanthia® antibody technology
  Product 2 therapeutic antibody
     

   
Record changed: 2019-01-23

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px



To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top